1. Home
  2. TONX vs PLX Comparison

TONX vs PLX Comparison

Compare TONX & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TON Strategy Company

TONX

TON Strategy Company

N/A

Current Price

$3.61

Market Cap

187.2M

ML Signal

N/A

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

N/A

Current Price

$2.67

Market Cap

182.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TONX
PLX
Founded
N/A
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.2M
182.9M
IPO Year
2013
1996

Fundamental Metrics

Financial Performance
Metric
TONX
PLX
Price
$3.61
$2.67
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
269.4K
★ 622.4K
Earning Date
11-11-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 69.21
N/A
EPS
N/A
★ 0.27
Revenue
$32,000.00
★ $52,744,000.00
Revenue This Year
N/A
$55.77
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$10.02
Revenue Growth
★ 433.33
N/A
52 Week Low
$1.75
$1.60
52 Week High
$7.14
$3.19

Technical Indicators

Market Signals
Indicator
TONX
PLX
Relative Strength Index (RSI) 56.13 59.49
Support Level $2.85 $2.21
Resistance Level $3.90 $2.82
Average True Range (ATR) 0.26 0.08
MACD 0.03 -0.01
Stochastic Oscillator 65.78 66.81

Price Performance

Historical Comparison
TONX
PLX

About TONX TON Strategy Company

TON Strategy Co is a digital asset treasury and Web3 ecosystem company focused on supporting The Open Network, a public blockchain integrated with Telegram and designed for fast, scalable transactions and decentralized applications. Its core business is managing its holdings of Toncoin (TON), including staking tokens to support network validation and earn rewards, while adhering to regulatory, accounting, and risk management standards. The company also pursues Web3 initiatives to support the ecosystem's growth and adoption. It operates through MARKET. live, Go Fund Yourself, and TON segments, with MARKET.live generating maximum revenue as a multi-vendor livestream shopping platform that combines e-commerce and entertainment across social and video channels.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: